Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer (Business Wire)
- Century Health and Arizona Gastrointestinal Associates Partner to Accelerate Real-World Evidence in IBD and MASH (PR Newswire)
- EF-YOLO: A novel AI model for high-precision detection of colorectal polyps (EurekAlert)
- Who’s winning, losing the physician practice acquisition race? (Becker’s Healthcare)
- Clinician-Industry Collaboration: A Clinical Review of Ethical, Strategic, and Practical Considerations (GI & Endoscopy News)
- Wanna Be Startin’ Somethin’? Advice for Initiating a New Line of Service (GI & Endoscopy News)
- The robotic penguin that makes endoscopy optional (Technology.org)
- Peptides, Colonoscopy, and the Inversion of Risk (Medscape)
